<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
--------------
Date of Report (Date of earliest event reported): DECEMBER 28, 2000
IBIS TECHNOLOGY CORPORATION
---------------------------
(Exact name of registrant as specified in its charter)
MASSACHUSETTS 0-23150 04-2987600
-------------- ------------- -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
32 CHERRY HILL DRIVE, DANVERS, MASSACHUSETTS 01923
-------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
<PAGE>
ITEM 5. OTHER EVENTS.
On December 28, 2000 the Registrant publicly disseminated a press
release announcing that it has licensed from IBM the right to manufacture and
sell SIMOX-SOI wafers using IBM's proprietary SIMOX process to IBM and all of
the Registrant's customers. Under this royalty-bearing license agreement, the
Registrant may use IBM's process to produce SIMOX-SOI wafers, which it will
market as Advantox-MLD(TM). A complementary product to the Registrant's existing
Advantox(R) product line, Advantox-MLD(TM) wafers will be broadly marketed to
integrated circuit manufacturers looking to accelerate their SOI adoption
process. Under this agreement the Registrant grants IBM rights to its patents
utilized in the modified low dose ("MLD") process. Additionally, as part of the
agreement the Registrant will grant IBM warrants to purchase the Registrant's
common stock.
The information contained in the press release is incorporated herein
by reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
------ ---------------------------------
(c) Exhibit.
99.1 The Registrant's Press Release dated December 28, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
---------------------------
(Registrant)
Date: December 28, 2000 /s/ DEBRA L. NELSON
------------------------------------
Debra L. Nelson, Chief Financial Officer
3
<PAGE>
EXHIBIT INDEX
EXHIBIT SEQUENTIAL
NUMBER DESCRIPTION PAGE NUMBER
99.1 The Registrant's Press Release 5
dated December 28, 2000
